Abstract: Various embodiments include a camera with folded optics and a bearing suspension arrangement. In some examples, a folded optics arrangement of the camera may include one or more lens elements and light path folding elements (e.g., prisms). Some embodiments include voice coil motor (VCM) actuator arrangements to move at least a portion of the optics arrangement along multiple axes.

Abstract: Various embodiments include a camera with folded optics and lens shifting capabilities. Some embodiments include voice coil motor (VCM) actuator arrangements to provide autofocus (AF) and/or optical image stabilization (OIS) movement. Some embodiments include suspension arrangements.

Abstract: Disclosed is a method of treating an animal exhibiting elevated body temperature or fever by administering to said animal an effective amount of a compound represented by the formula ##STR1## wherein R is a radical selected from the group consisting of phenyl; benzoyl; thenoyl; naphthoyl; phenylacetyl; mono-, di- or tri-halogen substituted benzoyl where the halogen substitution is on the phenyl ring; mono-, di- or tri-halogen substituted phenylacetyl where the halogen substitution is on the phenyl ring; phenylalkyl where the alkyl group contains from 1 to 4 carbon atoms; mono-, di- or tri-halogen substituted phenylalkyl where the alkyl group contains from 1 to 4 carbon atoms and the halogen is substituted on the phenyl ring and the pharmacologically acceptable acid addition salts thereof.

Abstract: Diclosed are compounds, having the following general formula, which are useful as analgesics and/or anti-inflammatory agents in living animals ##SPC1##Wherein R is a radical selected from the group consisting of hydrogen, aryl, alkenyl, aralkyl, halogen-substituted aralkyl, hydroxyl-substituted alkyl, arylsulfonyl, alicyclic, aroyl, alkylene dicarbonyl hexahydro-1H-furo (3,4-c)pyrrole, alkanoyl, arylene dicarbonyl hexahydro-1H-furo(3,4-c)pyrrole, halogen-substituted aroyl, arylethanoyl, halogen-substituted arylalkanoyl, halogen-substituted phenoxyalkanoyl, heteroaroyl, haloalkyl-substituted aroyl, alkyl-substituted aroyl, monoalkoxy-substituted aroyl, arylalkenoyl, hexahydrobenzoyl, alkanoyloxy-substituted aroyl, hydroxyl-substituted aroyl, and the pharmacologically acceptable acid addition salts thereof.

Abstract: Disclosed are compounds, having the following general formula, which are useful as analgesics in living animals. ##SPC1##Wherein R is a radical selected from the group consisting of aralkyl, aryl, aminoalkyl, arylalkanoyl, heteroaroyl, alkoxy substituted aroyl, alkenyl (C.sub.2 to C.sub.4), halogen substituted aralkyl, guanadinoalkyl, halogen substituted aroyl, alkyl substituted aroyl, halogen substituted arylalkanoyl, hexahydrobenzoyl, arylalkenoyl, o- or p-alkyl substituted phenylalkanoyl, alkyl substituted naphthylalkanoyl, alkanoyl (C.sub.3 to C.sub.20), haloalkyl substituted aroyl, alkoxy substituted aralkyl, heteroaralkyl, anilinocarbonyl, adamantanecarbonyl, arylsulfonyl, carboxyl substituted aroyl, hydroxyl substituted aroyl, alkanoyloxy substituted aroyl, arylglyoxylyl, alicyclic, arylene dicarbonyl-8-oxa-3-azabicyclo(3.2.1)octane, alkylene-8-oxa-3-azabicyclo (3.2.1)octane, alkylene dicarbonyl-8-oxa-3-azabicyclo(3.2.1)octane, and the pharmacologically acceptable acid addition salts thereof.